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Since posttraumatic stress disorder (PTSD) was first
recognized as a psychiatric disorder, it has generated
a great deal of scientific interest. Recent studies on
the neurobiology of PTSD provide evidence that PTSD
is biologically distinct from other types of traumatic
and nontraumatic stress responses. This paper reviews
three important directions of neurobiological
research in PTSD: noradrenergic axis changes and
associated alterations in autonomic responsivity, neu-
roendocrine changes involving the hypothalamic-pitu-
itary-adrenocortical (HPA) axis, and neuroanatomic
changes involving the hippocampus. Each section
reviews the salient aspects of preclinical research on
the biology of stress and their bearing on the under-
standing of PTSD, and summarizes prominent find-
ings from clinical biological studies of PTSD. Tenta-
tive models that integrate current findings from the
clinical study of PTSD are reviewed. To conclude, the
important methodological and empirical issues that
need to be addressed by future studies are indicated. 
ince posttraumatic stress disorder (PTSD)
was first recognized as a psychiatric disorder in the
Diagnostic and Statistical Manual of Mental Disorders,
3rd edition (DSM-III) in 1980,
1 it has generated
tremendous scientific and public interest.Research on
PTSD has only served to elucidate the great complex-
ity of this disorder. While early theoreticians viewed
PTSD as part of the continuum of normal stress
responses, recent studies indicate that the biological
patterns seen in PTSD are different from biological
responses to nontraumatic stress.
2 Researchers have
made important advances in characterizing the neuro-
biological features of PTSD and distinguishing biolog-
ical features associated with PTSD from patterns asso-
ciated with other types of reactions to traumatic and
nontraumatic stressors.This paper reviews three impor-
tant directions of neurobiological research in PTSD:
noradrenergic axis changes and associated alterations
in autonomic responsivity, neuroendocrine changes
involving the hypothalamic-pituitary-adrenal (HPA)
axis, and neuroanatomic changes involving the hip-
pocampus.
Noradrenergic axis function in PTSD
To react appropriately to danger, both animals and
humans must rapidly marshal a complex set of behav-
ioral responses. The locus ceruleus (LC), which is
located in the dorsal pons, plays a crucial role in acti-
vating central and peripheral nervous system responses
to threat.Through its broad connections with cortical
structures,the hippocampus,hypothalamus,amygdala,
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and spinal cord, the LC organizes affective, cognitive,
and motor responses to acute stressors.
3 Activation of
LC neurons leads to secretion of norepinephrine (NE),
which recruits the multiple pathways involved in mod-
ulating behavioral responses to acute stressors. For
example, upon receiving electrical stimulation to their
locus ceruleus, restrained monkeys will immediately
wake up and exhibit behaviors such as head and body
turning, eye scanning, tongue movement, hair pulling,
and escape struggling.These behavioral responses are
similar to those elicited when they are threatened in
their natural environment.
4
The noradrenergic system also modulates cognitive and
behavioral adaptations to chronic stressors. Repeated
exposure to a stressful stimulus leads to increased NE
secretion and facilitates the process of behavioral stress
sensitization, whereby the animal develops a height-
ened behavioral response to further presentations of
the same stimulus. Exposure to severe and repeated
stress depletes brain NE concentrations and leads to
behavioral changes such as decreased exploration in a
plus-maze novelty task,decreased appetite,and deficits
in previously well-learned behavioral tasks.
5 Such
behavioral changes induced by chronic stress have
been characterized by the term “learned helplessness.”
6
These animal models differ from PTSD in that the
development of stress sensitization and learned help-
lessness requires repeated exposure to stressful stimuli,
while PTSD can develop after only a single exposure to
traumatic stress. Despite this important difference,
stress sensitization and learned helplessness models
are useful in explaining behavioral changes associated
with PTSD, such as heightened reactions to trauma-
related stimuli and decreased interest in usual-life
activities.
7
Through its reciprocal connections with the amygdala,
the LC/NE axis also mediates classically conditioned
fear responses in animals. In this model, the repeated
pairing of a neutral stimulus such as a bright light with
a noxious stimulus, such as an electrical shock, even-
tually results in a conditioned fear response to the
previously neutral stimulus when it is presented
alone.
8 Reactivation of the neuronal connections
between the LC and amygdala that are established
during acute stress exposure may explain the failure
of animals to extinguish stress-related associations.
Conditioned fear patterns may underlie features of
PTSD such as heightened arousal responses to ordi-
nary noises and increased avoidance behaviors, while
failure of extinction may subserve persistent alarm
reactions to reminders of past trauma.
Research on noradrenergic function in PTSD includes
hormone- and receptor-binding assays, assessment of
autonomic reactivity, and pharmacological probes
involving central  2-adrenergic receptor agonists. One
method to assess noradrenergic function in PTSD has
been to measure plasma NE levels or levels of NE
metabolites in 24-hour urine collections. Studies have
found increased urinary concentrations of NE among
hospitalized PTSD patients compared with hospital-
ized patients with other mental disorders.
9 Similar
findings have been reported in sexually abused chil-
dren compared with healthy controls.
10 Other investi-
gators have noted decreases in the density of platelet
cell  2-adrenergic receptors in combat veterans with
PTSD and in traumatized children.
11,12 Reduction of
these NE-binding receptors may indicate an adaptive
downregulation in response to chronically elevated
plasma NE levels.
Since the noradrenergic axis also modulates periph-
eral autonomic responses, investigators have also
assessed noradrenergic function in PTSD by compar-
ing autonomic responses in PTSD subjects and con-
trols. Autonomic measures in these studies have
included heart rate, systolic and diastolic blood pres-
sure, and galvanic skin responses. While early stud-
ies
13,14 noted baseline autonomic differences between
combat veterans with PTSD and non-PTSD controls,
later studies
15-17 did not replicate these findings. This
may be due to the fact that earlier studies did not con-
trol for the effects of anticipatory anxiety and study
demand characteristics.
18,19 Studies that have compared
autonomic responses in PTSD and non-PTSD sub-
jects to stressful but nontraumatic stimuli such as hav-
ing to perform arithmetic calculations
20,21 or watch
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unpleasant films
16,22 have not identified autonomic dif-
ferences between PTSD subjects and controls. Thus,
there is little evidence to suggest that PTSD involves
changes in resting autonomic function or in auto-
nomic responsivity to nontraumatic stimuli.
In contrast to these negative findings, there is com-
pelling evidence to indicate that individuals with
PTSD exhibit an increased autonomic responsivity to
trauma-related stimuli. Compared with trauma-
exposed controls, PTSD subjects exhibit greater auto-
nomic arousal to trauma-related stimuli such as audio-
tapes of combat sounds,
13,14,23 videotapes of war zone
scenes,
16,24 and trauma-related smells.
25 Pitman et al
22
noted increased autonomic arousal in PTSD subjects
using a script-driven imagery technique in which
trauma survivors listened to their own trauma narra-
tive while viewing trauma-related slides. These find-
ings prompted a multisite Veterans Affairs Coopera-
tive Study to evaluate the diagnostic utility of
psychophysiological assessments in Vietnam combat
veterans with PTSD.
21 This study included three
groups: veterans with current PTSD (n=778), veter-
ans with lifetime but not current PTSD (n=181), and
veterans who never had PTSD (n=369). Using physi-
ological variables alone, researchers correctly classi-
fied 67% of the current PTSD group and a similar
percentage of the non-PTSD group. Collectively, these
studies suggest that increased autonomic reactivity to
traumatic stimuli is an important feature of many
individuals with PTSD.
Investigators have also examined noradrenergic axis
activity in PTSD using pharmacologic probes such as
yohimbine, which activates noradrenergic neurons in
the LC region by blocking inhibitory  2-adrenergic
autoreceptors at the presynaptic terminal.
26 South-
wick et al
27 found that after receiving yohimbine, a
subset of PTSD patients not only exhibited physio-
logical arousal such as increased heart rate and blood
pressure, but also developed severe anxiety symptoms
including acute panic attacks and increased PTSD
symptoms such as intrusive thoughts, flashbacks, and
emotional numbing.Yohimbine did not elicit similar
responses in trauma-exposed controls without PTSD.
Morgan et al
28 demonstrated that yohimbine infusion
enhanced acoustic startle responses in combat veter-
ans with PTSD, but did not affect startle responses in
combat veterans without PTSD. Consistent with psy-
chophysiologic findings, these result further support
the hypothesis that increased noradrenergic respon-
sivity is a core biological feature of PTSD.
Neuroendocrine changes in PTSD
Baseline neuroendocrine changes 
In addition to activating the noradrenergic system,
exposure to acute stress elicits important neuroen-
docrine changes that are modulated by the HPA axis.In
response to acute stress, corticotropin-releasing hor-
mone (CRH) is released from nuclei in the hypothala-
mus, amygdala, and cortex.
29 CRH is a 41–amino-acid
peptide that is transported to the anterior lobe of the
pituitary gland where it stimulates pituitary secretion of
adrenocorticotropic hormone (ACTH). ACTH enters
the systemic circulation and binds to cells in the adrenal
cortex, thereby stimulating the secretion of cortisol.
Cortisol is the primary stress hormone.Cortisol binds to
the type I and type II glucocorticoid receptors that are
present on cell membranes and activates a cascade of
physiologic stress responses involving altered metabo-
lism,increased cellular uptake of glucose,modulation of
immune activity,and induction of hepatic enzymes.This
has been reviewed by Michelson et al.
30 Cortisol also
blocks further secretion of CRH and ACTH, thereby
curtailing the acute stress response once the stress is
over.This is a crucial function of cortisol, since uncon-
trolled activation of acute stress hormones can signifi-
cantly harm host tissue. There is clear evidence from
animal studies that persistent activation of the HPA
axis by chronic and repetitive stress can have deleteri-
ous effects such as the acceleration of aging,disruption
of reproductive function, immunosuppression, and
reduced ability to fight cancers: these findings have
been reviewed by Johnson et al.
31
Noting that increased HPA axis activity is associated
with chronic stress in preclinical studies, investigators
initially predicted that individuals with PTSD would
have elevated plasma cortisol levels and would fail to
suppress cortisol levels after being administered dexa-
methasone.
32-34 However, evidence indicates that HPA
axis patterns in PTSD are quite different from patterns
seen in studies of chronic nontraumatic stress. Mason
and colleagues
32 first noted that veteran inpatients with
PTSD had lower 24-hour urinary cortisol levels than
other psychiatric inpatients.This finding has been repli-




35,37-39 controls and in other trauma-exposed pop-
ulations such as holocaust survivors,
39 rape victims,
34,40
and adolescents exposed to a natural disaster.
41 This
literature has been reviewed in detail by Yehuda.
42
However, not all studies have obtained similar find-
ings.
11 Differences in study results may reflect differ-
ences in study settings, different assay techniques, and
patient differences such as inpatient versus outpatient
status,obesity,substance abuse,use of medications,and
comorbid illnesses.
43Associated research has examined
diurnal fluctuations in plasma cortisol levels in PTSD.
Two studies have found that cortisol release in PTSD
patients is comparable to that of healthy subjects dur-
ing the daytime (7 AM to 7 PM), but significantly lower
during the late evening and early morning, leading to
wider diurnal fluctuations in the PTSD group.
36,44 Other
studies have examined target receptor alterations in
PTSD and have identified increased glucocorticoid
receptors on lymphocyte cell membranes in PTSD sub-
jects compared with controls.
45-48 Collectively, these
studies indicate that basal cortisol secretion is altered
in PTSD.
Changes in dynamic 
neuroendocrine responses
To evaluate the dynamic responsivity of the HPA axis
in PTSD,investigators have used exogenous hormones
that stimulate or inhibit the HPA axis at a specific
locus.A well-established paradigm involves measuring
ACTH and cortisol levels after administering dexa-
methasone.
• Dexamethasone is a synthetic glucocorticoid that
mimics the negative feedback effects of cortisol on
the HPA axis.It inhibits ACTH release from the pitu-
itary gland,which subsequently leads to a decrease in
serum cortisol levels.Four studies have reported that,
in response to dexamethasone, individuals with
PTSD demonstrate a more robust suppression of
ACTH and cortisol release that normal controls.
48-50
This contrasts with the nonsuppression of cortisol
levels seen in almost half of all depressed patients
after dexamethasone administration.
51
• Other studies have measured ACTH and cortisol lev-
els after infusing CRH,which stimulates the pituitary
gland to release ACTH.Two studies found decreased
ACTH responses to CRH infusion in adult PTSD
subjects compared with controls,
49,52 while another
study
10 found no differences in ACTH response to
CRH infusion in sample of adolescent girls.
• Finally,metyrapone,which blocks the synthesis of cor-
tisol in the adrenal gland, has been used to examine
hypothalamic and pituitary responses to decrease cor-
tisol in PTSD. One study found that PTSD patients
show larger increases in ACTH levels following
metyrapone administration that do normal controls.
53
These findings led Yehuda and colleagues
42 to propose
that PTSD may involve an HPA axis that is character-
ized by enhanced sensitivity to feedback inhibition.
According to this model,individuals with PTSD expe-
rience chronic and recurrent stress events that lead to
increased secretion of CRH. Pituitary sensitivity to
CRH decreases the need to compensate for increased
CRH release,as reflected by blunted ACTH responses
to CRH infusion. To protect against the toxic effects
of elevated cortisol, the HPA axis in PTSD becomes
increasingly sensitized to feedback inhibition from cor-
tisol through upregulation of glucocorticoid receptors
and other mechanisms.This is evidenced by low base-
line ACTH and cortisol levels and robust suppression
of ACTH and cortisol release after dexamethasone
administration.By tightly controlling cortisol secretion
and responding aggressively to acute rises in cortisol
levels, the neuroendocrine system may serve to buffer
vulnerable neuronal structures such as the hippocam-
pus from cellular toxicity induced by elevated serum
cortisol levels.
54,55
Neuroanatomic changes in PTSD
While evidence that severe stress can affect noradren-
ergic and neuroendocrine function has been well-estab-
lished,recent animal studies have identified important
neurotic effects of stress-mediated increases in gluco-
corticoid levels. One neuroanatomical structure that
appears to be particularly susceptible to stress-induced
damage is the hippocampus,which is involved in learn-
ing and memory circuits. Studies of monkeys exposed
to the stressors of disrupted attachment found damage
to cells in the hippocampal region
56;similar patterns of
cell damage could be induced by implanting glucocor-
ticoids directly into the hippocampus.
57 This suggests
that elevated glucocorticoid levels,such as might occur
acutely during exposure to traumatic stress,could lead
Basic research27
to hippocampal damage. Other studies examining
stress-induced hippocampal damage in mice have iden-
tified important memory deficits that are correlated
with the extent of hippocampal damage,
58 suggesting
that structural damage to the hippocampus may also be
associated with functional memory deficits.
These findings have led investigators to hypothesize
that PTSD may be associated with hippocampal
changes resulting from either the acute neurotoxic
effects of elevated serum cortisol during exposure to
traumatic stress or the gradual deterioration result-
ing from glucocorticoid-mediated effects of chronic
stress. Using magnetic resonance imaging (MRI) tech-
niques to measure hippocampal volume, Bremner et
al
59 compared hippocampal size in 26 male Vietnam
combat veterans with PTSD and 22 healthy controls,
and found a statistically significant 8% reduction in
right hippocampal volume in the PTSD group. How-
ever, this difference was not associated with PTSD
symptoms or combat exposure. Gurvits and col-
leagues
60 compared hippocampal volumes in veterans
with PTSD (n=7) and matched controls (n=7). The
PTSD group showed bilateral reductions in hip-
pocampal size (26% on the left, 22% on the right),
which remained significant after controlling for age,
brain volume, drinking history, and combat exposure.
Total hippocampal size was negatively correlated with
combat exposure (r=-0.72, P=0.003) and number of
PTSD symptoms (r=-0.78, P=0.001), but only weakly
associated with memory performance. Examining a
different population, Bremner et al
61 compared hip-
pocampal volumes in adult child abuse survivors with
PTSD (n=17) versus healthy controls (n=17) and
found a statistically significant 12% reduction in left
hippocampal size in the PTSD group after control-
ling for alcohol use, age, and educational status. How-
ever, hippocampal volume was not associated with
memory deficits, number of PTSD symptoms, or expo-
sure. Finally, Stein et al
62 examined hippocampal vol-
umes in 21 female survivors of childhood sexual abuse
with PTSD and 21 nonvictimized controls, and noted
a statistically significant 5% reduction in left hip-
pocampal size in the abused group. Combining MRI
measurements with proton magnetic resonance spec-
troscopy (MRSI), Schuff et al
63 observed a 6%
decrease in right hippocampal volume which was
associated with an 18% decrease in hippocampal
activity as measured by the ratio of N-acetyl aspar-
tate signal activity to that of choline and creatinine.
Their results suggest that utilizing MRSI measure-
ment may enhance our ability to detect subtle hip-
pocampal changes in PTSD.While the above studies
included only adults, De Bellis et al
64 compared hip-
pocampal size in 43 abused children with PTSD and 61
matched controls, and found no corresponding
decrease in hippocampal volume in the PTSD group.
Collectively, these studies provide preliminary evi-
dence that changes in hippocampal size and function
may be an important feature of chronic PTSD.
Conclusion and future directions
The findings reviewed in this paper provide tantalizing
new insights into PTSD and offer the promise of a richer
understanding of this complex disorder. However, for
these findings to be truly meaningful,important empirical
questions need to be addressed. Most studies have
employed a cross-sectional design and included PTSD
subjects who suffer from comorbid disorders such as
major depression or alcohol abuse.This makes it difficult
to identify whether a biological finding associated with
PTSD represents a premorbid condition, reflects the
impact of a comorbid disorder, or actually results from
PTSD.There is a need for prospective longitudinal studies
to measure biological variables prior to the onset of
PTSD and track their change across time. Furthermore,
animal models of PTSD have primarily examined bio-
logical responses that develop over days to weeks: find-
ings from such animal models may be less applicable to a
disorder such as PTSD, which develops over a period of
months to years.Improved animal paradigms are needed
to anchor future research in the biology of PTSD.
65
Another critical issue is to determine which biological
responses in PTSD are similar to biological stress
responses in other populations,and which biological pat-
terns are uniquely associated with PTSD. Exciting
research lies ahead and promises to advance our scientific
understanding of this major public health challenge. ❏
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Hallazgos neurobiológicos en el
trastorno de estrés postraumático: 
una revisión
Desde que fue reconocido por primera vez el trastorno
de estrés postraumático (TEPT) como una patología
psiquiátrica, se ha generado bastante interés científico.
Estudios recientes acerca de la neurobiología del TEPT
aportan evidencias que el TEPT es biológicamente dis-
tinto de otros tipos de respuestas de estrés traumático o
no traumático.Este artículo revisa tres importantes líne-
as de la investigación neurobiológica en el TEPT: a)
cambios en el eje noradrenérgico y alteraciones asocia-
das a la respuesta autonómica, b) cambios neuroendo-
crinos en el eje hipotálamo-hipófisis-adrenal (HHA) y
c) cambios neuroanatómicos que afectan al hipocampo.
Cada sección revisa los aspectos más destacados de la
investigación preclínica en la biología del estrés y su
relación con la comprensión del TEPT, y resume los
hallazgos principales de los estudios clínico biológicos
del  TEPT.También se revisan algunos modelos tentati-
vos que integran los hallazgos actuales de los estudios
clínicos del TEPT. Para concluir, se mencionan los
temas importantes metodológicos y empíricos que
requieren ser abordados en futuros estudios.
Données neurobiologiques dans les
états de stress post-traumatique : revue
Depuis que les états de stress post-traumatique (ESPT)
ont été assimilés à une maladie psychiatrique,ils ont sus-
cité un intérêt scientifique important.Des études récentes
portant sur la neurobiologie des ESPT ont apporté la
preuve que cette pathologie est biologiquement distincte
des autres types de réponses à un stress traumatisant ou
non traumatisant.Cet article passe en revue trois impor-
tantes voies de recherche en neurobiologie des ESPT :
les modifications de l’axe noradrénergique et les altéra-
tions associées de la réponse autonome, les modifica-
tions neuroendocrines impliquant l’axe hypothalamo-
hypophyso-surrénalien, et les modifications neuroanato-
miques impliquant l’hippocampe.Chaque partie examine
les aspects marquants de la recherche préclinique de la
biologie du stress et leur contribution à la compréhen-
sion des ESPT,et fait le point sur les principaux résultats
issus des études biologiques et cliniques des ESPT. Des
modèles provisoires intégrant ces résultats sont suggérés.
Enfin, les problèmes méthodologiques et empiriques
qu'il sera important de prendre en compte dans les
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